Related Experiment Video
Updated: Jun 14, 2026
09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Neuronutrition and Alzheimer's disease
Balenahalli N Ramesh1, T S Sathyanarayana Rao, Annamalai Prakasam
1Biochemistry and Nutrition, Central Food Technological Research Institute, CSIR Unit, Mysore, India.
Journal of Alzheimer'S Disease : JAD
|March 24, 2010
Summary
Dietary choices significantly impact Alzheimer's disease (AD) risk. Rich diets in antioxidants, vitamins, and polyphenols may prevent AD, while certain metal ions contribute to its development.
Area of Science:
- Neurology
- Nutritional Science
- Biochemistry
Background:
- Alzheimer's disease (AD) is a complex neurological disorder influenced by genetic and environmental factors.
- Dietary patterns, including saturated fatty acids, alcohol, antioxidants, and vitamins, play a crucial role in AD onset.
- Metal ions (Pb, Fe, Al, Cu, Zn) are implicated in AD pathogenesis by catalyzing free radical production.
Purpose of the Study:
- To review beneficial dietary strategies for preventing Alzheimer's disease (AD).
- To explore the role of dietary components, including polyphenols and metal ions, in AD.
- To summarize evidence on diet's impact on AD pathogenesis and prevention.
Main Methods:
- Literature review summarizing existing research on diet and Alzheimer's disease.
- Analysis of studies investigating the effects of specific nutrients, polyphenols, and metal ions on AD.
- Compilation of evidence on dietary interventions and their potential in AD prevention.
Main Results:
- Diets high in unsaturated fatty acids, vitamins, antioxidants, and wine may suppress AD onset.
- Polyphenols and spices can prevent oxidative damage by scavenging free radicals.
- Dietary polyphenols' metal-chelating properties may offer protection against AD.
Conclusions:
- Dietary modifications represent a promising approach for Alzheimer's disease prevention.
- Routine consumption of polyphenol-rich foods could be protective against AD.
- Understanding dietary influences is key to developing effective AD management strategies.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...